Evaluated articles

Showing page 344 of 1181 pages of list content

SARS-CoV-2 Omicron efficiently infects human airway, but not alveolar epithelium

This article has 17 authors:
1. Mart M. Lamers
2. Anna Z. Mykytyn
3. Tim I. Breugem
4. Nathalie Groen
5. Kèvin Knoops
6. Debby Schipper
7. Romy van Acker
8. Petra B. van den Doel
9. Theo Bestebroer
10. Charlotte D. Koopman
11. Chantal Reusken
12. Mauro J. Muraro
13. Corine H. GeurtsvanKessel
14. Martin E. van Royen
15. Peter J. Peters
16. Jingshu Zhang
17. Bart L. Haagmans
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Jan 20, 2022Latest activity Jan 22, 2022
Prediction and validation of host cleavage targets of SARS-CoV-2 3C-like protease

This article has 10 authors:
1. Nora Yucel
2. Silvia Marchiano
3. Evan Tchelepi
4. Germana Paterlini
5. Quentin McAfee
6. Nehaar Nimmagadda
7. Andy Ren
8. Sam Shi
9. Charles Murry
10. Zoltan Arany
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Jan 19, 2022Latest activity Jan 22, 2022
NRP1 and furin as putative mediators of SARS-CoV-2 entry into human brain cells

This article has 7 authors:
1. Ashutosh Kumar
2. Ravi K. Narayan
3. Sujeet Kumar
4. Vikas Pareek
5. Chiman Kumari
6. Rakesh K. Jha
7. Pranav Prasoon
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Jan 20, 2022Latest activity Jan 22, 2022
Serum extracellular vesicles profiling is associated with COVID‐19 progression and immune responses

This article has 3 authors:
1. Kevin Ho Wai Yim
2. Simone Borgoni
3. Richard Chahwan
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Apr 1, 2022Latest activity Jan 22, 2022
Nirmatrelvir, Molnupiravir, and Remdesivir maintain potent in vitro activity against the SARS-CoV-2 Omicron variant

This article has 12 authors:
1. Romel Rosales
2. Briana L. McGovern
3. M. Luis Rodriguez
4. Devendra K. Rai
5. Rhonda D. Cardin
6. Annaliesa S. Anderson
7. PSP study group
8. Emilia Mia Sordillo
9. Harm van Bakel
10. Viviana Simon
11. Adolfo García-Sastre
12. Kris M. White
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Jan 19, 2022Latest activity Jan 21, 2022
High activity of an affinity-matured ACE2 decoy against Omicron SARS-CoV-2 and pre-emergent coronaviruses

This article has 5 authors:
1. Joshua J. Sims
2. Sharon Lian
3. Rosemary L. Meggersee
4. Aradhana Kasimsetty
5. James M. Wilson
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Aug 25, 2022Latest activity Jan 21, 2022
Differences in environmental stability among SARS-CoV-2 variants of concern: Omicron has higher stability

This article has 9 authors:
1. Ryohei Hirose
2. Yoshito Itoh
3. Hiroshi Ikegaya
4. Hajime Miyazaki
5. Naoto Watanabe
6. Takuma Yoshida
7. Risa Bandou
8. Tomo Daidoji
9. Takaaki Nakaya
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Feb 2, 2022Latest activity Jan 21, 2022
Detection of SARS-CoV-2 Variants Mu, Beta, Gamma, Lambda, Delta, Alpha, and Omicron in Wastewater Settled Solids Using Mutation-Specific Assays Is Associated with Regional Detection of Variants in Clinical Samples

This article has 7 authors:
1. Marlene Wolfe
2. Bridgette Hughes
3. Dorothea Duong
4. Vikram Chan-Herur
5. Krista R. Wigginton
6. Bradley J. White
7. Alexandria B. Boehm
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Apr 26, 2022Latest activity Jan 21, 2022
Effectiveness of mRNA COVID-19 vaccines against Omicron and Delta variants in a matched test-negative case–control study among US veterans

This article has 12 authors:
1. Yinong Young-Xu
2. Gabrielle M Zwain
3. Hector S Izurieta
4. Caroline Korves
5. Ethan I Powell
6. Jeremy Smith
7. Abirami Balajee
8. Mark Holodniy
9. David O Beenhouwer
10. Maria C Rodriguez-Barradas
11. Sheldon T Brown
12. Vincent C Marconi
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Aug 1, 2022Latest activity Jan 21, 2022
Estimation of the COVID-19 Average Incubation Time: Systematic Review, Meta-analysis and Sensitivity Analyses

This article has 2 authors:
1. Yijia Weng
2. Grace Y.Yi
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Jan 18, 2022Latest activity Jan 21, 2022
Systematic recovery of building plumbing-associated microbial communities after extended periods of altered water demand during the COVID-19 pandemic

This article has 10 authors:
1. Solize Vosloo
2. Linxuan Huo
3. Umang Chauhan
4. Irmarie Cotto
5. Benjamin Gincley
6. Katherine J Vilardi
7. Byungman Yoon
8. Kelsey J Pieper
9. Aron Stubbins
10. Ameet Pinto
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Jan 18, 2022Latest activity Jan 21, 2022
Multisystemic inflammatory syndrome following COVID-19 mRNA vaccine in children: a national post-authorization pharmacovigilance study

This article has 24 authors:
1. Naïm Ouldali
2. Haleh Bagheri
3. Francesco Salvo
4. Denise Antona
5. Antoine Pariente
6. Claire Leblanc
7. Martine Tebacher
8. Joëlle Micallef
9. Corinne Levy
10. Robert Cohen
11. Etienne Javouhey
12. Brigitte Bader-Meunier
13. Caroline Ovaert
14. Sylvain Renolleau
15. Veronique Hentgen
16. Isabelle Kone-Paut
17. Nina Deschamps
18. Loïc De Pontual
19. Xavier Iriart
20. Christelle Gras-Le Guen
21. François Angoulvant
22. Alexandre Belot
23. the “French Covid-19 Paediatric Inflammation Consortium”
24. the “French Pharmacovigilance network”
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Jan 18, 2022Latest activity Jan 21, 2022
Nirmatrelvir, an orally active Mpro inhibitor, is a potent inhibitor of SARS-CoV-2 Variants of Concern

This article has 12 authors:
1. Devendra K. Rai
2. Irina Yurgelonis
3. Patricia McMonagle
4. Hussin A. Rothan
5. Li Hao
6. Alexey Gribenko
7. Elizabeth Titova
8. Barry Kreiswirth
9. Kris M. White
10. Yuao Zhu
11. Annaliesa S. Anderson
12. Rhonda D. Cardin
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Jan 19, 2022Latest activity Jan 21, 2022
Noncommunicable diseases risk factors and the risk of COVID-19 among university employees in Indonesia

This article has 5 authors:
1. Indah Suci Widyahening
2. Dhanasari Vidiawati
3. Trevino A. Pakasi
4. Pradana Soewondo
5. Abdillah Ahsan
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Jun 6, 2022Latest activity Jan 21, 2022
Structural basis for the in vitro efficacy of nirmatrelvir against SARS-CoV-2 variants

This article has 12 authors:
1. Samantha E. Greasley
2. Stephen Noell
3. Olga Plotnikova
4. RoseAnn Ferre
5. Wei Liu
6. Ben Bolanos
7. Kimberly Fennell
8. Jennifer Nicki
9. Tim Craig
10. Yuao Zhu
11. Al E. Stewart
12. Claire M. Steppan
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Jun 1, 2022Latest activity Jan 21, 2022
ELF5 is a potential respiratory epithelial cell-specific risk gene for severe COVID-19

This article has 19 authors:
1. Maik Pietzner
2. Robert Lorenz Chua
3. Eleanor Wheeler
4. Katharina Jechow
5. Julian D. S. Willett
6. Helena Radbruch
7. Saskia Trump
8. Bettina Heidecker
9. Hugo Zeberg
10. Frank L. Heppner
11. Roland Eils
12. Marcus A. Mall
13. J. Brent Richards
14. Leif-Erik Sander
15. Irina Lehmann
16. Sören Lukassen
17. Nicholas J. Wareham
18. Christian Conrad
19. Claudia Langenberg
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Aug 15, 2022Latest activity Jan 21, 2022
Population-level implications of the Israeli booster campaign to curtail COVID-19 resurgence

This article has 4 authors:
1. Nir Gavish
2. Rami Yaari
3. Amit Huppert
4. Guy Katriel
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Jun 1, 2022Latest activity Jan 21, 2022
SARS-CoV-2 infection results in lasting and systemic perturbations post recovery

This article has 23 authors:
1. Justin J. Frere
2. Randal A. Serafini
3. Kerri D. Pryce
4. Marianna Zazhytska
5. Kohei Oishi
6. Ilona Golynker
7. Maryline Panis
8. Jeffrey Zimering
9. Shu Horiuchi
10. Daisy A. Hoagland
11. Rasmus Møller
12. Anne Ruiz
13. Jonathan B. Overdevest
14. Albana Kodra
15. Peter D. Canoll
16. James E. Goldman
17. Alain C. Borczuk
18. Vasuretha Chandar
19. Yaron Bram
20. Robert Schwartz
21. Stavros Lomvardas
22. Venetia Zachariou
23. Benjamin R. tenOever
Reviewed by Rapid Reviews Infectious Diseases, ScreenIT

This article has 3 evaluationsAppears in 2 listsLatest version Jan 20, 2022Latest activity Jun 7, 2022
COVID-19 Breakthrough Infection after Inactivated Vaccine Induced Robust Antibody Responses and Cross-Neutralization of SARS-CoV-2 Variants, but Less Immunity against Omicron

This article has 19 authors:
1. Nungruthai Suntronwong
2. Ritthideach Yorsaeng
3. Jiratchaya Puenpa
4. Chompoonut Auphimai
5. Thanunrat Thongmee
6. Preeyaporn Vichaiwattana
7. Sitthichai Kanokudom
8. Thaneeya Duangchinda
9. Warangkana Chantima
10. Pattarakul Pakchotanon
11. Suvichada Assawakosri
12. Pornjarim Nilyanimit
13. Sirapa Klinfueng
14. Lakkhana Wongsrisang
15. Donchida Srimuan
16. Thaksaporn Thatsanatorn
17. Natthinee Sudhinaraset
18. Nasamon Wanlapakorn
19. Yong Poovorawan
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Mar 3, 2022Latest activity Jan 21, 2022
Understanding evolution of COVID-19 driven mortality rate

This article has 5 authors:
1. Ishika Bhaumik
2. Suman Sinha-Ray
3. Anshul Chaudhary
4. Abhishek Srivastava
5. Prashant Kodgire
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Jan 18, 2022Latest activity Jan 21, 2022